• Medical Translation
    • Medical Translation Services
      • COVID-19 Emergency Response Team
      • CTD/eCTD Submission
      • Linguistic Validation
      • eLearning & Training
      • Back Translation
      • Creative Communication
      • Terminology Management
      • Software Localization
      • Medical Document Translation Services
      • Linguistic Testing
      • Machine Translation Post-Editing
      • In-Country Review
      • Multilingual Desktop Publishing (DTP)
      • Technical Translation
      • Pharmacovigilance
      • Clinical Studies
      • Patient Recruitment
  • Industries
    • Medical Devices
    • Hospital Translation
    • Chemical Translations
    • In-Vitro Diagnostic Devices
    • Pharmaceuticals
    • Biotechnology
    • Health Science Legal Translation Services
    • Government, NGO & Non-Profit
  • Interpretation
    • Interpretation Services
      • CDE Pre IND/NDA Meeting
      • Medical Conferences
      • Phone Interpretation
      • Video Interpretation
  • Executive Management
  • HealthFirst 100
    • About HealthFirst 100
      • Health
      • Articles
      • News
      • White Papers & Case Studies
  • CSOFT International
  • English
    • 简体中文
    • Español
  • CSOFT International
  • News & Events
  • Careers
  • Contact
  • English
    • 简体中文 (Chinese (Simplified))
    • Español (Spanish)
  • CSOFT International
  • CSOFT International
  • CSOFT International
  • CSOFT International
CSOFT Health Sciences
  • Medical Translation
    • Medical Translation Services
      • COVID-19 Emergency Response Team
      • CTD/eCTD Submission
      • Linguistic Validation
      • eLearning & Training
      • Back Translation
      • Creative Communication
      • Terminology Management
      • Software Localization
      • Medical Document Translation Services
      • Linguistic Testing
      • Machine Translation Post-Editing
      • In-Country Review
      • Multilingual Desktop Publishing (DTP)
      • Technical Translation
      • Pharmacovigilance
      • Clinical Studies
      • Patient Recruitment
  • Industries
    • Medical Devices
    • Hospital Translation
    • Chemical Translations
    • In-Vitro Diagnostic Devices
    • Pharmaceuticals
    • Biotechnology
    • Health Science Legal Translation Services
    • Government, NGO & Non-Profit
  • Interpretation
    • Interpretation Services
      • CDE Pre IND/NDA Meeting
      • Medical Conferences
      • Phone Interpretation
      • Video Interpretation
  • Executive Management
  • HealthFirst 100
    • About HealthFirst 100
      • Health
      • Articles
      • News
      • White Papers & Case Studies
  • CSOFT International
  • English
    • 简体中文
    • Español
Select Page
AstraZeneca Unlikely to Receive EUA Approval Until April

AstraZeneca Unlikely to Receive EUA Approval Until April

Dec 31, 2020 | News, Regulatory

According to Operation Warp Speed Chief, Moncef Slaoui, the AstraZeneca and Oxford University vaccine may not receive the U.S. Food and Drug Administration’s Emergency Use Approval (EUA) until April, despite the UK’s approval yesterday (12/30). Questions...
Analysis on Pfizer’s COVID-19 Vaccine Distribution Leaves Many Healthcare Workers Unprotected

Analysis on Pfizer’s COVID-19 Vaccine Distribution Leaves Many Healthcare Workers Unprotected

Dec 4, 2020 | News, Regulatory

Countrywide, hospitals are preparing for the first 3.2 million shipments of Pfizer’s COVID-19 vaccine. The first round of shipments will be distributed to five government agencies before Moderna’s vaccine hits the market. State’s will have final say on...
Review of Johnson & Johnson’s COVID-19 Vaccine Underway

Review of Johnson & Johnson’s COVID-19 Vaccine Underway

Dec 1, 2020 | News, Regulatory

After finding that the Johnson & Johnson vaccines triggered antibody cell formation to fight COVID-19, the European Medicines Agency (EMA) began to review the drug for emergency use authorization (EUA). Meanwhile, the company’s rivals Moderna and...
Moderna COVID-19 Vaccince Candidate Shows 95% Efficacy Rate

Moderna COVID-19 Vaccince Candidate Shows 95% Efficacy Rate

Nov 16, 2020 | News, Regulatory

Based on long-term data from a late-stage trial including 30,000 participants, Moderna’s vaccine candidate has shown results of a 95% efficacy rate in fighting COVID-19. Moderna is planning to file for Emergency Use Authorization (EUA) in the coming weeks, ad by...

Recent Posts

  • Sinopharm Unit and CanSinoBio apply for Public Use Approval of COVID-19 Vaccine in China
  • FDA Makes Recommendations for COVID-19 Variants
  • FDA Clears Brainlab Loop-X Mobile Imaging Robot and Cirq Robotic Alignment Module
  • FDA Approves First Ever 3D-Printed Bone Replacement
  • Translating TMFs for Global Clinical Trials

Topics

  • CFDA
  • Classification System
  • Clinical Trials
  • e-Labeling
  • e-Learning
  • EMA
  • Events
  • FDA
  • Globalization
  • Health
  • Healthcare
  • In-Country Review
  • Innovation
  • Interpretation
  • Language Service Provider
  • Linguistic Validation
  • Machine Translation
  • Medical Translation
  • Medical Writing
  • Mistranslations
  • Mobile Translation
  • News
  • Pharmaceuticals
  • Quality
  • Regulatory
  • Resources
  • Social Media
  • Special stories
  • Terminology
  • Transcreation
  • Website Translation
  • Translation
  • CTD/eCTD Submission
  • Clinical Studies
  • Clinical Trials
  • Linguistic Validation
  • Back Translation
  • Medical Writing
  • eLearning & Training
  • Creative Communication
  • Terminology Management
  • Interpretation
  • CDE Pre IND/NDA Meeting
  • Medical Conferences
  • Over the Phone
  • Medical Writing
  • Regulatory Writing
  • Medico-Marketing
  • Publication Writing
  • Medical Writing Safety Writing
  • Lay Summaries
  • Informed Consent Form Translation
  • Patient Safety Narratives
  • Advisory Boards
  • Summaries of Safety
  • Asia Regulatory Services
  • Asia Market Access
  • Asia Regulatory Strategy
  • Clinical Trials in Asia
Environmental Responsibility and Sustainability at CSOFT
    ISO 9001 and ISO 13485 Certified © 2021 CSOFT International, Inc.    Terms of Use    Privacy Policy